Clovis Oncology, Inc. (CLVSQ) vs Dare Bioscience, Inc. (DARE)
- Clovis Oncology, Inc. CLVSQ
- Dare Bioscience, Inc. DARE 0.72 −2.70%
Clovis Oncology, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. Clovis Oncology, Inc. and Dare Bioscience, Inc. are of similar size ($14.6M and $14.2M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −14.8%. Clovis Oncology, Inc. has the higher net margin (−189.4% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clovis Oncology, Inc. leads on 11 and Dare Bioscience, Inc. on 5.
Valuation
Profitability
| Metric | CLVSQ | DARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 72.21% | 58.84% | 65.16% |
| Operating margin | (155.38%) | (813.35%) | 0.00% |
| Net margin | (189.37%) | (804.33%) | 0.00% |
| Free cash flow margin | (132.19%) | (849.36%) | 0.00% |
| Return on equity | 78.31% | 165.29% | (56.36%) |
| Return on assets | (58.94%) | (62.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack